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Abstract
Licorice extracts contain various useful substances for oral health. Alkaline extract 
showed potent anti‐HIV activity, whereas flavonoid‐rich water extracts showed potent 
anti‐HSV activity, closely correlated with polarizability, ionization potential, a number of 
ring systems, atomic number and mass. Licorice flavonoids showed higher tumor‐speci‐
ficity against human oral squamous cell carcinoma as compared with human normal 
oral mesenchymal cells. Glycyrrhiza, at noncytotoxic concentrations, potently inhibited 
the IL‐1β‐induced inflammation in cultured human gingival and periodontal ligament 
fibroblasts. Glycyrrhizin, a major component of Glycyrrhiza, showed the highest UV‐
protected activity. The results suggest the possible applicability of licorice extracts for 
several oral diseases and cosmetic products.
Keywords: herb extract, licorice, flavonoids, antiviral activity, tumor‐specificity, anti‐
UV activity, anti‐inflammatory activity, oral environment
1. Introduction
The oral cavity (mouth) includes the lips, cheeks, palate (roof of the mouth), floor of the 
mouth, and the part of the tongue in the mouth (oral tongue). The oral cavity is important 
for food digestion and speech, the taste buds for sensing different tastes, and the mouth for 
breathing, drinking, facial expressions, and social interactions.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativeco mons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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It is now accepted that the improvement of oral environment leads to the enrichment of qual‐
ity of life. The number of healthy teeth in aged people well correlates with longevity. In Japan, 
many of Kampo medicines and component herb extracts have been applied to various oral 
diseases. However, the selection of Kampo medicines in each case is mostly depended on the 
experiences of attending physicians, due to the absence of a quantitative evaluation method 
of their efficacy. This urged us to establish the quick in vitro quantification method of antivi‐
ral, antitumor, anti‐inflammatory, and anti‐UV activity, using appropriate cultured cells [1]. 
These methods were applied to various Kampo medicines and component extracts of plants 
including licorice to clarify their relative potency.
It was the best to use oral cells for the study of oral diseases. Therefore, we used oral squa‐
mous cell carcinoma cell lines and normal oral cells for the study of antitumor activity, and 
human gingival and periodontal ligament fibroblasts for the study of anti‐inflammatory 
activity. However, we rather used nonoral cells for the study of antiviral and anti‐UV activity 
due to their higher sensitivity (T‐cell leukemia and Vero cells for HIV and HSV infection) and 
also considering the target specificity (skin cells for UV‐irradiation).
2. Biological activity of licorice extracts and purified components
2.1. Preparation of flavonoid and chalcone derivatives
For the preparation of licorice flavonoids, the air‐dried roots of Glycyrrhiza inflate were 
extracted with MeOH under reflux. The MeOH extracts were dried in vacuo and passed 
through a Diaion HP‐20 column, eluting sequentially with H
2
O, 50% EtOH and EtOH. The 
50% EtOH eluate was chromatographed on a silica gel column (CHCl
3
:MeOH:H
2
O = 10:5:1) 
to give two fractions. The latter fraction was chromatographed on an octa decyl silyl (ODS) 
column (MeOH:H
2
O, 45:55) to give three fractions. From the first fraction, liquiritin apio‐
side, liquiritigenin 7‐apiosylglucoside, liquiritin, and neoliquiritin were obtained with high‐
performance liquid chromatography (HPLC) (YMC‐Pack Pro C18; MeOH:H
2
O, 40:60 and 
CH
3
CN:H
2
O, 22:78). From the second fraction, isoliquiritin apioside, licurazid, isoliquiritin, 
and neoisoliquiritin were obtained with HPLC (YMC‐Pack Pro C18, MeOH:H
2
O, 50:50, and 
CH
3
CN:H
2
O, 30:70). From the third fraction, liquiritigenin and isoliquiritigenin were obtained 
with recycling HPLC (JAI‐gel GS‐310, MeOH) [2]. The structures of these compounds are 
shown in Figure 1.
For the preparation of water and alkaline extracts, the licorice roots (Glycyrrhiza glabra har‐
vested in Afghanistan) were extracted for 20 h with water (not adjusted or adjusted to pH 9 
or pH 12) at room temperature. These extracts were filtered through a membrane filter (pore 
size: 5 μm), neutralized with NaOH or H
2
SO
4
 and then dried to obtain the water extract (A), 
alkaline (pH 9.0) extract (B) and alkaline (pH 12.0) extract (C) at the yield of 18.0, 20.3, and 
21.7%, respectively (Figure 2A). Two alkaline solutions (pH 9.0 and pH 12.0) extracted these 
ingredients at higher yield than water extraction. Glycyrrhizic acid was the most abundant 
compound in these extracts, followed by liquiritin apioside and licurazid (Figure 2b) [3].
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2.2. Antiviral activity
2.2.1. Anti‐HIV activity
Human T‐cell leukemia virus I (HTLV‐I)‐bearing CD4‐positive human T‐cell line MT‐4 
was cultured in suspension in an RPMI‐1640 medium supplemented with 10% FBS and 
infected with human immunodeficiency virus (HIV)‐1IIIB at a multiplicity of infection of 0.01. HIV‐ and mock‐infected MT‐4 cells were incubated for 5 days with different concen‐
trations of extracts and the relative viable cell number was determined by MTT assay. The 
Figure 1. Structures of licorice root flavonoids.
Figure 2. (A) Fractional preparation of water and alkaline extracts from licorice root (G. glabra) and distribution of major 
ingredients. (B) Major ingredients in each extract. Cited from Ref. [3].
Applicability of Licorice Extracts for Treatment of Oral Diseases, Evaluated by Simplified In Vitro Assay Systems...
http://dx.doi.org/10.5772/67435
93
concentrations that reduced the viable cell number by 50% (CC
50
) and that increased the 
number of viable HIV‐infected cells to 50% of control (EC
50
) were determined from the 
dose‐response curve. The anti‐HIV activity was evaluated by the selectivity index (SI) (SI 
= CC
50
/EC
50
). Infection of MT‐4 cells with HIV‐1 reduced the cell viability to almost zero. 
Alkaline extract of licorice root (G. Glabra) showed the protective effect on HIV infection 
(SI > 9.2), although its anti‐HIV activity was much lower than that of anti‐HIV agents 
[azidothymidine (AZT), 2′,3′‐dideoxycytidine (ddC)] (SI = 3029–11,715) and an alkaline 
extract of the leaves of Sasa senanensis Rehder (SE) (SI = 42.7) (left column, Table 1). On 
the other hand, water extract of licorice root, flavonoid‐rich fraction, glycyrrhizin acid, 
glycyrrhetinic acid, flavonoids (iquiritin apioside, liquiritin 7‐apiosylglucose, liquiritin, 
neoliquiritin, liquiritigenin, isoliquiritin apioside, lucurzid, isoliquiritin, neoisoliquiri‐
tin, isoliquiritigenin), and polymethoxyflavonoids (tricin, 3,3′,4′,5,6,7,8‐heptamethoxy‐
flavone, nobiletin, tangeretin, sudachitin) were all inactive (SI < 1), due to their higher 
cytotoxicity [4].
Anti‐HIV 
activity (SI)
Anti‐HSV activity Antitumor activity (TS)
SI Maximum  
cell recovery 
(%)
Epithel. Tumor/
Mesen. normal 
(Method I)
Gingiva. Tumor/
Gingiva. normal 
(Method II)Method I Method II
Licorice root extracts
Water extract (μg/ml) >1.3 ><1 >4.6 60 ><1 ><1
Purified fraction of water 
extract (μg/ml)
<1 3.4 6.8 50 >3.5 4.2
Flavonoid‐rich fraction of 
water extract (μg/ml)
<1 4.6 9.2 69 5.5 5.2
Water extract (different lot) 
(pH 5.6) (μg/ml)
><1 <1 2.0 57 ><1 ><1
Alkaline (pH 9.0) extract 
(μg/ml)
>3.0 <1 3.2 62 ><1 ><1
Alkaline (pH12.0) extract 
(μg/ml)
>9.2 <1 <1 49 ><1 ><1
Glycyrrhizin acid (μg/ml) >1.2 <1 <1 ND ><1 ><1
Glycyrrhetinic acid (μg/ml) <1 <1 <1 ND 1.1 1.1
Licorice flavonoids
Liquiritin apioside (μg/ml) ><1 >5 >500 79 ><1.0
Liquiritin 7‐apiosylglucose 
(μg/ml)
><1 ><1 >21 58 1.0
Liquiritin (μg/ml) <1 <1 2.8 55 >1.7
Neoliquiritin (μg/ml) <1 <1 2.9 59 ><0.9
Liquiritigenin (μg/ml) <1 2.4 >6 77 2.0
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Ten Kampo medicine and 25 constituent herb extracts showed little or no anti‐HIV activity 
(SI = 1–4) (Table 2) [15], possibly due to the fact that most of them were prepared by hot 
water extraction.
Anti‐HIV 
activity (SI)
Anti‐HSV activity Antitumor activity (TS)
SI Maximum  
cell recovery 
(%)
Epithel. Tumor/
Mesen. normal 
(Method I)
Gingiva. Tumor/
Gingiva. normal 
(Method II)Method I Method II
Isoliquiritin apioside (μg/ml) ><1 23.1 >455 82 ><1.1
Lucurzid (μg/ml) ><1 ><1 >667 65 9.0
Isoliquiritin (μg/ml) <1 21.4 128.6 97 2.2
Neoisoliquiritin (μg/ml) <1 8.0 10.9 87 ><0.9
Isoliquiritigenin (μg/ml) <1 <1 2.0 54 4.4
Licochalcone A (μg/ml) 2.0
Polymethoxyflavonoids
Tricin (μM) <1 5.8 7.0 67 ><1.0 ><1.0
3,3',4',5,6,7,8‐
Heptamethoxyflavone (μM)
<1 <1 1.1 50 2.0 2.8
Nobiletin (μM) <1 <1 <1 42 2.0 1.8
Tangeretin (μM) <1 <1 <1 45 3.0 2.4
Sudachitin (μM) <1 <1 <1 42 2.9 1.7
Positive control
AZT (μM) 11,715
ddC (μM) 3029
Epigallocatechin gallate (μM) <1 4.7 62
Chlorogenic acid (μM) <1 <1 49
Coumaric acid (μM) <1 <1 69
Curcumin (μM) 1.9 ND 75
Resveratrol (μM) <1 2.8 55
Doxorubicin (μM) 69.9 54.8
5‐FU (μM) >8.9 >28.8
Methotexate (μM) >170 >45
SE (%) 42.7 8.7 10.2 100 1.6 1.5
Table 1. Anti‐HIV, anti‐HSV, and antitumor activity of licorice extracts. Cited from Ref. [4].
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Name Glycyrrhizin 
content (mg/g)
LPS contamination 
(ng/g)
Anti‐UV activity (SI) Anti‐HIV activity 
SI
HSC‐2 HaCaT
Constituent herb extracts
Alisma rhizome <0.1 <2 ><1.0 11 ><1.0
Asiasarum root <0.1 2 ><1.0 >13 <1.0
Astragalus root <0.1 17 ><1.0 >13 ><1.0
Atractylodes lancea 
rhizome
<0.1 16 <0.8 <0.1 >1.9
Bupleurum root <0.1 17 <0.7 <0.1 ><1.0
Cimicifuga 
rhizome
<0.1 15 >1.4 9.7 <1.0
Cinnamon bark <0.1 13 <0.6 7.1 <1.0
Cnidium rhizome <0.1 18 ><1.0 >9.2 >1.5
Coptis rhizome <0.1 16 1.5 13 <1.0
Gardenia fruit <0.1 15 >8 >23 >2.7
Ginger <0.1 14 <0.8 <0.3 ><1.0
Ginseng <0.1 18 ><1.0 >7.1 ><1.0
Glycyrrhiza 175.4 19 4.3 4.4 <1.0
Japanese 
Angelica root
<0.1 18 ><1.0 >3.9 >1.1
Japanese Gentian <0.1 16 >1.1 >20 ><1.0
Jujube <0.1 16 ><1.0 >3 ><1.0
Peony root <0.1 16 ><1.0 >18 <1.0
Phellodendron 
bark
<0.1 14 <0.1 10 <1.0
Pinellia tuber <0.1 <2 ><1.0 >3.7 ><1.0
Platycodon root <0.1 18 <0.8 <0.15 ><1.0
Polyporus 
sclerotium
<0.1 19 >1.0 >26 >4.4
Poria sclerotium <0.1 <2 ><1.0 4.8 ><1.0
Rehmannia root <0.1 10 ><1.0 >7.1 ><1.0
Saposhnikovia root <0.1 13 >1.3 >20 ><1.0
Scutellaria root <0.1 <2 <0.9 38 <1.0
Chinese 
medicines
Byakkokaninjinto 7.2 17 ><1.0 3.5 <1.0
Hangesyashinto 16.2 9 >4.9 >28 <1.0
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2.2.2. Anti‐HSV activity
We have recently established the simple in vitro assay method of antiherpes simplex virus (HSV) 
activity. Vero cells, isolated from the kidney of African green monkey (Cercopithecus aethiops), 
[5] were infected with HSV‐1 (multiplicity of infection = 0.01). First, HSV‐1 and test samples 
were mixed and stood for 20 min, and the mixture was then added to the adherent Vero cells. 
After incubation for 4 days, the relative viable cell number was quantified by MTT reagent to 
yield CC
50
, EC
50
, and selectivity index (SI) (SI = CC
50
/EC
50
). By infection with HSV‐1, the cell via‐
bility dropped to 34.1 ± 8.9% (18.3–51.1%) (n = 33). Addition of licorice root extracts recovered 
the cell density to 51–64% of control level. The incomplete recovery of cell viability urged us 
to adopt the following two methods for measuring EC
50
. In method 1, EC
50
 was defined as the 
concentration at which the viability was restored to the midpoint between that of HSV‐infected 
cells and that of mock‐infected cells. In method II, EC
50
 was defined as the concentration at 
which the viability was restored to 50% that of mock‐infected cells (see example in Figure 3) [4].
It was unexpected that water extract of licorice root [SI = >< 1 (method I); 4.6 (method II)] 
showed higher anti‐HSV activity than alkaline extract (pH 12) (SI < 1 and < 1). Among water 
extracts, flavonoid‐rich fraction showed the highest anti‐HSV activity (SI = 4.6; 9.2). Among 
licorice flavonoids, liquiritin apioside (SI >5; >500), isoliquiritin apioside (SI >23.1; >455), 
lucurzid (SI >< 1; >667) and isoliquiritin (SI = 21.4; 128.6) showed the highest anti‐HSV activity 
(center column in Table 1).
Among five polymethoxyflavonoids, the SI value for tricin (SI = 5.8; 7.0) (Figure 1) was 
comparable with that of SE, while the other four polymethoxyflavonoids (3,3′,4′,5,6,7,8‐
heptamethoxyflavone, nobiletin, tangeretin, sudachitin) had little or no anti‐HSV activity 
Name Glycyrrhizin 
content (mg/g)
LPS contamination 
(ng/g)
Anti‐UV activity (SI) Anti‐HIV activity 
SI
HSC‐2 HaCaT
Hotyuekkito 0.2 11 ><1.0 >5.1 ><1.0
Juzentaihoto 7 18 ><1.0 >9.6 <1.0
Kikyoto 50.3 18 1.05 4.4 <1.0
Ninjinyoeito 3.5 19 ><1.0 23 ><1.0
Rikkosan 24.1 >200 >1.2 >6.8 <1.0
Saireito 7 17 >3.4 >19 <1.0
Shosaikoto 9.2 19 >4.3 34 <1.0
Unseiin <0.1 >200 >4.9 >23 <1.0
Glycyrrhizin <1 20.6 36.4 >2.0
Vitamin C 44 200
AZT 17,850
Table 2. Anti‐UV and anti‐HIV activity of Kampo medicine and constitutional plant extract. Cited from Refs. [15, 16].
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(SI < 1; < 1–1.1) (Table 1). Among lower molecular polyphenols, epigallocatechin gallate, a 
major compound in green tea, had some anti‐HSV activity (SI < 1; 4.7), followed by resve‐
ratrol (SI < 1; 2.8).
The quantitative structure‐activity relationship (QSAR) analysis [4] demonstrated that anti‐
HSV activity of licorice flavonoids and lower molecular weight polyphenols correlated well 
with six chemical descriptors that represent polarizability (MATS5p, GATS5p) [6, 7], ioniza‐
tion potential (GATS5i) [7], a number of ring systems (NRS) [8], and atomic number (J_Dz(Z)) 
and mass (J_Dz(m) [9] (r2 = 0.684, 0.627, 0.624, 0.621, 0.619 and 0.618, respectively, p < 0.0001) 
(Figure 4). This result suggests that the physicochemical properties, rather than the category 
of compound, are important for determining anti‐HSV activity.
2.3. Antitumor activity
The tumor‐selectivity index (TS) was calculated by dividing the mean CC
50
 against normal 
cells by the mean CC
50
 against tumor cells. We used the following two methods. Method I: 
Figure 3. Anti‐HSV activity of flavonoid‐rich fraction of water extract of liquorice root. Each value represents the mean 
± SD of triplicate assays. The 50% effective concentration (EC
50
), determined by method I or II (see Table 2), and 50% 
cytotoxic concentration (CC
50
) is indicated by arrows. Cited from Ref. [4]. Cited from Ref. [3].
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human gingival fibroblast (HGF) + human periodontal fibroblast (HPLF) + human pulp cells 
(HPC) (normal mesenchymal cells) versus Ca9‐22 + HSC‐2 + HSC‐3 + HSC‐4 (human oral 
squamous cell carcinoma) (epithelial cells). Method II: HGF (gingival normal mesenchymal 
cells) versus Ca9‐22 (gingival tumor epithelial cells) [10] (Table 1). We have confirmed that 
the TS value reflects the antitumor activity, based on the finding that antitumor drugs have 
extremely higher TS values [11].
Among licorice root extracts, flavonoid‐rich fraction of water extract showed the highest TS 
[TS = 5.5 (method I); 5.2 (method II)], although this value was much lower than that of popular 
antitumor drugs (doxorubicin, 5‐fluorouracil, methotrexate, melphalan: TS = 8.9–170). Among 
licorice flavonoids, neoisoliquiritin apioside and isoliquiritigenin exhibited the highest antitu‐
mor activity (TS = 4.4–9.0), which was well correlated with their solvation energy (r2 = 0.659) 
(QSAR analysis) [2]. Five polymethoxyflavonoids (tricin, 3,3′,4′,5,6,7,8‐heptamethoxyflavone, 
nobiletin, tangeretin, and sudachitin) were weakly tumor selective (TS = 1.0–3.0) (right col‐
umn, Table 1) [4].
2.4. Anti‐inflammatory activity
We found that interleukin (IL)‐1β stimulated the production of prostaglandin (PG)E
2
, interleukin 
(IL)‐6, IL‐8, and monocyte chemoattractant protein‐1 (MCP‐1) by human gingival fibroblast (HGF) 
Figure 4. QSAR analysis of anti‐HSV activity (defined as SI value determined by method II) of licorice flavonoids, 
polymethoxyflavonoids, and low molecular weight flavonoids. The log SI value was calculated from ‐logCC
50
 value 
and ‐logEC
50
 value. 1, liquiritin apioside; 2, liquiritin 7‐apiosylglucose; 3, liquiritin; 4, neoliquiritin; 5, liquiritingenin; 
6, isoliquiritin apioside; 7, lucurzid; 8, isoliquiritin; 9, neoisoliquiritin; 10, isoliquiritigenin; 11, tricin; 12, 3,3′,4′,5,6,7,8‐
heptamethoxyflavone; 13, nobiletin; 14, tangeretin; 15, sudachitin; 16, epigallocatechin gallate; 17, chlorogenic acid; 18, 
coumaric acid; 20, resveratrol. The data of curcumin, 19, was not included since the SI value could not be obtained (center 
column, Table 1). Cited from Ref. [4].
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to much higher extent than that achieved by LPS prepared from Escherichia coli and Porphyromonas 
gingivalis [12]. Glycyrrhiza extract significantly inhibited the IL‐1β‐stimulated PGE
2
 production 
by HGF cells (EC
50
 = 95 μg/ml, CC
50
 > 4000 μg/ml; SI = CC
50
/EC
50
 > 22) (Figure 5A). Similarly, 
glycyrrhiza extract significantly inhibited the IL‐1β‐stimulated PGE
2
 production by human peri‐
odontal ligament fibroblasts (HPLF) cells (EC
50
 = 32 μg/ml, CC
50
 = 1878 μg/ml; SI = CC
50
/EC
50
 = 59) 
(Figure 5B) [13]. The endospecy test with LAL reagent revealed that LPS contamination in glycyr‐
rhiza and glycyrrhizin was very low (19 ng/g and <1 ng/g, respectively) (Table 2) [14].
2.5. Anti‐UV activity
We measured the ability of test samples to protect the UV‐induced injury (referred to as anti‐
UV activity), using UV‐sensitive cell line HSC‐2 cell. We found that glycyrrhizin, a major com‐
ponent of Glycyrrhiza, exhibited very high anti‐UV activity (SI = 20.6) (Figure 6A, Table 2). 
In order to determine whether there is any correlation of anti‐UV activity and glycyrrhizin 
content, we investigated the concentration of glycyrrhizin in the plant extracts and Kampo 
medicines by HPLC [JASCO PU‐980 pump, a JASCO UV‐970 UV/VIS detector, Inertsil ODS‐3 
column, 254 nm; mobile phase: 2.5% acetic acid (40: 60)]. Twenty‐five plant extracts, except 
for Glycyrrhiza (175.4 mg/g), did not contain detectable amounts of glycyrrhizin, whereas 10 
Figure 5. Anti‐inflammatory activity of glycyrrhiza extract. HGF (A) and HPLF (B) were incubated for 24 h without 
(control) or with 5 ng/ml IL1‐β in the presence of the indicated concentrations of glycyrrhiza extract, and the relative 
viable cell number was determined by the MTT method, and the extracellular PGE
2
 production was determined by 
ELISA (Kato, unpublished data).
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Kampo medicines (Byakkokaninjinto, Hangesyashinto, Hotyuekkito, Juzentaihoto, Kikyoto, 
Ninjinyoeito, Rikkosan, Saireito, Shosaikoto, Unseiin) contained up to 50.3 mg/g of glycyr‐
rhizin, possibly due to the inclusion of Glycyrrhiza (Table 2). However, there was no clear‐cut 
relationship between the anti‐UV activity and glycyrrhizin content of Kampo medicines and 
constituent plant extracts [15] (Table 2).
Western blot analysis demonstrated that UV irradiation induced the production of cleaved 
PARP, indicating the activation of caspase‐3/‐7 in HSC‐2 cells, and that glycyrrhiza inhibited 
the UV‐induced caspase activation (Figure 6B).
Since it is preferable to use skin‐derived cells for the determination of anti‐UV activity, we inves‐
tigated the anti‐UV activity of Kampo medicines using human immortal skin keratinocyte cell 
line HaCaT. We found that the HaCaT cell system gave nearly 1 order higher SI value than the 
HSC‐2 system, maintaining good correlation of anti‐UV activity measured between these two cell 
lines (r2 = 0.33) (Figure 7A). There was some correlation between the anti‐UV activity (defined as 
SI value) and absorbance at 253.7 nm in both systems (r2 = 0.14 and 0.24, respectively) (Figure 7B), 
suggesting that some part of anti‐UV activity comes from the direct absorption of UV.
Figure 6. (A) Anti‐UV activity of glycyrrhiza (left) and glycyrrhizin (right), (B) protective effect of glycyrrhiza on the 
UV‐induced apoptosis in HSC‐2 cells (western blot analysis). Cited from Ref. [15].
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Among 10 Kampo medicines, Shosaikoto (SI = 34) showed the highest anti‐UV activity, fol‐
lowed by Hangesyashinto (SI > 28), Unseiin (SI > 23), Ninjinyoeito (SI = 23), and Saireito (SI > 19), 
whereas other four Kampo medicines were much less active (SI < 9.6) (Table 2). Among 25 plant 
extracts, Scutellaria root exhibited the highest anti‐UV activity (SI = 38), followed by Polyporus 
sclerotium (SI > 26), Gardenia fruit (SI > 23), Japanese Gentian (SI > 20), and Saposhnikovia root 
(SI > 20). Glycyrrhizin also exhibited potent anti‐UV activity (SI = 36) (Table 2) [16].
3. Conclusions
Alkaline extract of licorice roots showed greater anti‐HIV activity than the water extract, 
while the water extract, especially the flavonoid‐rich fraction, showed greater anti‐HSV activ‐
ity than the alkaline extract (Table 1), suggesting that water and alkaline extracts might show 
different site of actions against these two viruses.
It was unexpected that five polymethoxyflavonoids including tricin showed very low level of 
anti‐HSV activity (Table 1), since tricin has been reported to show a broad antiviral spectrum 
[17–20]. It remains to be investigated whether the combination of these compounds with acy‐
clovir [5] or ganciclovir [21] may increase viability of infected cells.
The present study also demonstrated that neoisoliquiritin apioside showed the highest anti‐
tumor activity. Isoliquiritin has been reported to inhibit granuloma angiogenesis and tube 
formation in vascular endothelial cells [22]. Further studies are required to elucidate the 
mechanism by which this compound induces such high tumor specificity.
We have recently reported that titanium dioxide nanoparticles (TiO
2
 NPs) were incorporated into 
vacuoles of HGF cells and aggravated the gingival inflammation (characterized by the enhanced 
prostaglandin E
2
 production and COX‐1 and COX‐2 protein expression, and the reduction of 
intracellular concentrations of amino acid, urea cycle, polyamine, S‐adenosylmethione and 
glutathione synthetic pathways) [23]. This finding recommends carful use of dental materials 
containing TiO
2
 NPs for patients with gingivitis or periodontitis. It remains to be investigated 
whether glycyrrhiza extracts or their fractions can neutralize the aggravation effects of TiO
2
 NPs.
Figure 7. (A) Correlation between anti‐UV activities measured in HSC‐2 cells and that in HaCaT cells. (B) The correlation 
of anti‐UV activity and absorbance (optical density) measured at 253.7 nm (Kato et al., unpublished data).
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More than 80 reports have investigated the anti‐inflammatory effect of Kampo medicines 
(reviewed in Refs. [24] and [25]). However, basic research and clinical studies for the treat‐
ment of oral diseases are much less [26–30], and little is known about the relative potency of 
Kampo medicines. Potent antiviral, anti‐inflammatory, antitumor, and anti‐UV activities of 
licorice extracts, demonstrated here, suggest their possible applicability for treating several 
oral diseases and manufacturing cosmetic products.
QSAR analysis is a useful technique to predict the most active three‐dimensional structure. 
The next step is to synthesize the compound with predicted structure and then investigate 
the biological activity. This prediction‐synthesis‐confirmation cycle should be repeated until 
obtaining the expected biological activity (Figure 8). The applicability of such compounds on 
oral diseases should be tested.
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